Buchumschlag

Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells

Background: The mechanisms of drug resistance of cancer have not been yet elucidated in details. Recently, the role of mast cells (MCs) in the development of drug resistance has been brought in the limelight. The aim of the study was to examine the morphological features of doxorubicin (DOX)-resista...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental Oncology
Datum:	2018
Hauptverfasser:	Boroday, N.V., Chekhun, V.F.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2018
Schlagworte:	Original contributions
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/139246
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells / N.V. Boroday, V.F. Chekhun // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 42-47. — Бібліогр.: 30 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
von: Todor, I.N., et al.
Veröffentlicht: (2015)

Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
von: I. N. Todor, et al.
Veröffentlicht: (2015)

Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
von: Chekhun, V.F., et al.
Veröffentlicht: (2018)

Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
von: Lukyanova, N.Yu., et al.
Veröffentlicht: (2009)

Metalloproteins during development of Walker-256 carcinosarcoma resistant phenotype
von: V. F. Chekhun, et al.
Veröffentlicht: (2015)

Magnetic nanotherapy of animals with carcinosarcoma Walker-256
von: V. E. Orel, et al.
Veröffentlicht: (2014)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
von: Todor, I.N., et al.
Veröffentlicht: (2012)

Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
von: Rusetskaya, N.V., et al.
Veröffentlicht: (2009)

Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
von: Rusetskaya, N.V., et al.
Veröffentlicht: (2011)

Structural changes of serum albumin in response to oxidative stress caused by Walker-256 carcinosarcoma growth
von: Sarnatskaya, V.V., et al.
Veröffentlicht: (2023)

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2016)

The influence of lactoferrin on elemental homeostasis and activity of metal-containing enzymes in rats with Walker-256 carcinosarcoma
von: Lozovska, Yu.V., et al.
Veröffentlicht: (2023)

Proinflammatory effects of photoactivated methylene blue on rat model of Walker 256 carcinosarcoma
von: Petrellis, M.C., et al.
Veröffentlicht: (2023)

Change of morphostructural characteristics and metabolic profile of Walker-256 carcinosarcoma under the impact of exogenous lactoferrin
von: L. A. Nalieskina, et al.
Veröffentlicht: (2020)

Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model
von: Zykova, M.G., et al.
Veröffentlicht: (2012)

Photodynamic responsiveness of human leukemia Jurkat/A4 cells with multidrug resistant phenotype
von: Philchenkov, A.A., et al.
Veröffentlicht: (2014)

Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells
von: Pan, Y.Y., et al.
Veröffentlicht: (2007)

Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
von: Timovska, Yu.O., et al.
Veröffentlicht: (2009)

Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
von: Yurchenko, O.V., et al.
Veröffentlicht: (2010)

Endometrial stromal cells: isolation, expansion, morphological and functional properties
von: Zlatska, A.V., et al.
Veröffentlicht: (2017)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2016)

Assessment of the effect of wave device application on morphological changes in organs and cells of irradiated animals
von: Bebeshko, V., et al.
Veröffentlicht: (2017)

Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
von: Burlaka, A.P., et al.
Veröffentlicht: (2015)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Jurkat/A4 cells with multidrug resistance exhibit reduced sensitivity to quercetin
von: Philchenkov, A., et al.
Veröffentlicht: (2010)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: Chekhun, S., et al.
Veröffentlicht: (2013)

Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
von: Zadvornyi, T.V., et al.
Veröffentlicht: (2018)

Autogeneic RNA-electroporated CD40-ligand activated B-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo
von: Shen, S., et al.
Veröffentlicht: (2007)

Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
von: Chekhun, V.F., et al.
Veröffentlicht: (2014)

DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells
von: Svirnovski, A.I., et al.
Veröffentlicht: (2010)

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
von: Sviezhentseva, I.O., et al.
Veröffentlicht: (2015)

Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
von: Lukyanova, N.Yu.
Veröffentlicht: (2010)

Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
von: Potebnya, G.P., et al.
Veröffentlicht: (2009)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: Chekhun, V.F., et al.
Veröffentlicht: (2015)

Experimental validation of prevention of the development of stochastic effects of low doses of ionizing radiation based on the analysis of human lymphocytes’ chromosome aberrations
von: Domina, E.A., et al.
Veröffentlicht: (2013)

Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT resistant PC-3 and CPT-sensitive LNCaP cells
von: Mizutani, K., et al.
Veröffentlicht: (2006)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: Chekhun, S.V., et al.
Veröffentlicht: (2014)

The effect of cytostatics and hyperthermia on RAJI human lymphoma cells
von: Istomin, Yu.Р., et al.
Veröffentlicht: (2011)

Efects of PDT with 5-aminolevulinic acid and chitosan on Walker carcinosarcoma
von: Filip, A., et al.
Veröffentlicht: (2008)